PATENT CLAIM ANALYSIS

Application Number: 16281751
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "093210"]

Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.

Claim (Index 5):
A cell comprising one or more polynucleotides of  claim 2 , wherein the zinc finger nuclease is expressed in the cell.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 99.0
- Lexical Diversity: 1.22222
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14013250', '15927357', '15172626', '15511858', '14013236']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8079924970738972
- 35 USC 102 Novelty (BERT): 0.5742213615445192
- Combined Prediction Score: 0.7846153835209594
- Mean Citation Score: 404.95884
- Max Citation Score: 433.9003
- Similarity Product: 303.35760417540075

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test